June 12, 2020 / 6:38 AM / 25 days ago

BRIEF-Oryzon Genomics Presents Positive New Efficacy Data From Ongoing Phase Ii Alice Trial

June 12 (Reuters) - Oryzon Genomics SA:

* PRESENTS POSITIVE NEW EFFICACY DATA FROM ONGOING PHASE II ALICE TRIAL FOR IADADEMSTAT IN COMBINATION WITH AZACITIDINE IN ELDERLY PATIENTS WITH ACUTE MYELOID LEUKEMIA Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below